News | May 15, 2001

Pharsight Trial Simulator version 2.1.1 released

Pharsight Corporation, a leading provider of software products and consulting service that help reduce the complexity, cost and duration of pharmaceutical development, announced the release of version 2.1.1 of its popular Pharsight Trial Simulator (PTS) software.

This new update of the software includes support for Windows 2000 and the S-PLUS 2000 R4 for Pharsight. The update is available free of charge to existing PTS users via Pharsight's support website at support.pharsight.com. The support website now offers ftp download capabilities to help speed up the receipt of users' updates.

A more efficient approach to computer-assisted trial design (CATD), Pharsight Trial Simulator balances ease-of-use with powerful tools for defining study design attributes, statistical analysis, sensitivity analysis and creating graphical summaries. The Pharsight Trial Simulator, enables the entire clinical development team to improve access to existing scientific knowledge, communicate and test ideas, and plan relevant, effective trials for every phase of clinical drug testing. Companies can anticipate risks and preview the range of expected results before R&D dollars are committed to further development of a drug, and human subjects are exposed to experimental therapies. More information on the enhancements in version 2.1.1 is available at www.pharsight.com/tools/pts/new.htm .

About Pharsight Corporation
Pharsight Corporation develops and markets products and services that help pharmaceutical and biotechnology companies improve their decision-making in drug development and commercialization. By integrating scientific, clinical and business decision criteria into a dynamic, model-based methodology, Pharsight helps its customers optimize the value of their drug development programs and portfolios from discovery to post-launch marketing and any point in between. Pharsight uses computer-based drug-disease models, dynamic predictive market models, clinical trial simulation and advanced valuation models to create a continuously evolving view of its customers' development efforts and product portfolios. This enables decision makers to make explicit value-driven trade-offs throughout the development and commercialization process. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available on the World Wide Web at www.pharsight.com.

Source: Pharsight Corporation

Subscribe to our free e-mail newsletter.

Click for a free Buyer's Guide listing.